Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.

Support the Forward

Funded by readers like you DonateSubscribe
Fast Forward

Fact check: Israel is not about to release a coronavirus vaccine

Despite rumors swirling online to the contrary, Israel has not developed and tested a vaccine for coronavirus.

The rumor appears to have started with a Facebook post that read, “A vaccine for CoronaVirus has just been approved in Israel. It is being produced in hundreds of thousands as we speak and expected to be in the US within 14 days!” Israel’s reputation as the “Start-Up Nation,” a tech, biotech and engineering juggernaut, made the rumor seem more credible.

In fact, Haaretz reports that Israel’s Institute for Biological Research is expected to announce the development of a vaccine, but clinical trials and other experiments may take months before the vaccine is made available to the public.

Similarly, MIGAL Galilee Research Institute, which is state-funded, is adapting an bronchial virus vaccine to function as a COVID-19 vaccine.

One former Health Ministry official told the Times of Israel that it could be 18 months before a vaccine is ready.

Molly Boigon is an investigative reporter at the Forward. Contact her at [email protected] or follow her on Twitter @MollyBoigon

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.